On the recordApril 26, 2016
the challenges associated with developing treatments and the investments we make to develop novel medicines, that is really completely a red herring with respect to Syprine.
Source
congress.govEditor's note · Context
Kaine criticizes Valeant's justification for price increases on Syprine.
Share
More from Tim Kaine
Jul 30, 2026
The entire committee believes she’s very well-qualified, and so the question was, ‘Will she have the backbone to stand up against any anti-science if she’s pushed?’
Jul 31, 2026
The Shenandoah Valley Battlefields National Historic District is one of Virginia’s great historical treasures, preserving the Valley’s Civil War battlefields so that Americans from across the country can visit them and reflect on our…
Other voices in this conversation
